In rodents, reduced insulin/IGF1 signaling slows aging and therefore prevents development of neurodegenerative diseases [107] but normal aging is associated with declining levels of IGF1 and administration of insulin can improve cognitive function in AD patients [108, 109]. Here, IGF1 is linked to neurodegenerative disease.